Cargando…

Serum Levels of the Cytokine TWEAK Are Associated with Metabolic Status in Patients with Prostate Cancer and Modulate Cancer Cell Lipid Metabolism In Vitro

SIMPLE SUMMARY: TWEAK is an inflammatory cytokine related to prostate cancer (PCa) progression that exerts its effects by engaging its cognate receptor Fn14. A soluble form of TWEAK (sTWEAK) has been detected in the PCa microenvironment. Altered levels of circulating sTWEAK are associated with aberr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altuna-Coy, Antonio, Ruiz-Plazas, Xavier, Alves-Santiago, Marta, Segarra-Tomás, José, Chacón, Matilde R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465414/ https://www.ncbi.nlm.nih.gov/pubmed/34572917 http://dx.doi.org/10.3390/cancers13184688

Ejemplares similares

Biofluid quantification of TWEAK/Fn14 axis in combination with a selected biomarker panel improves assessment of prostate cancer aggressiveness
por: Ruiz-Plazas, Xavier, et al.
Publicado: (2019)

In silico analysis of prognostic and diagnostic significance of target genes from prostate cancer cell lines derived exomicroRNAs
por: Altuna-Coy, Antonio, et al.
Publicado: (2023)

Liquid Biopsy-Based Exo-oncomiRNAs Can Predict Prostate Cancer Aggressiveness
por: Ruiz-Plazas, Xavier, et al.
Publicado: (2021)

The lipidomic profile of the tumoral periprostatic adipose tissue reveals alterations in tumor cell’s metabolic crosstalk
por: Altuna-Coy, Antonio, et al.
Publicado: (2022)

A Serum Biomarker Panel of exomiR-451a, exomiR-25-3p and Soluble TWEAK for Early Diagnosis of Rheumatoid Arthritis
por: Rodríguez-Muguruza, Samantha, et al.
Publicado: (2021)

Inflammatory Cytokines and Survival Factors from Serum Modulate Tweak-Induced Apoptosis in PC-3 Prostate Cancer Cells
por: Sanz, Ana Belen, et al.
Publicado: (2012)

TWEAK: A New Player in Obesity and Diabetes
por: Vendrell, Joan, et al.
Publicado: (2013)

Reduced circulating sTWEAK levels are associated with metabolic syndrome in elderly individuals at high cardiovascular risk
por: Díaz-López, Andrés, et al.
Publicado: (2014)

A serum metabolic biomarker panel for early rheumatoid arthritis
por: Rodríguez-Muguruza, Samantha, et al.
Publicado: (2023)

Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer
por: Pardo, Juan C., et al.
Publicado: (2022)

Glycolysis at 75: is it time to tweak the first elucidated metabolic pathway in history?
por: Schurr, Avital, et al.
Publicado: (2015)

The TWEAK/Fn14/CD163 axis—implications for metabolic disease
por: Ratajczak, Wiktoria, et al.
Publicado: (2021)

Serum Levels of TWEAK and Scavenger Receptor CD163 in Type 1 Diabetes Mellitus: Relationship with Cardiovascular Risk Factors. A Case-Control Study
por: Llauradó, Gemma, et al.
Publicado: (2012)

Targeting lipid metabolism in metastatic prostate cancer
por: Scheinberg, Tahlia, et al.
Publicado: (2023)

TWEAKing death
por: Ashwell, Jonathan D.
Publicado: (2008)

New insights into lipid metabolism and prostate cancer (Review)
por: Zhang, Zhengliang, et al.
Publicado: (2023)

Serum lipids and prostate cancer
por: Garrido, Manuel M., et al.
Publicado: (2021)

TWEAK Promotes Peritoneal Inflammation
por: Sanz, Ana Belen, et al.
Publicado: (2014)

TWEAK/Fn14 Signaling Axis Mediates Skeletal Muscle Atrophy and Metabolic Dysfunction
por: Sato, Shuichi, et al.
Publicado: (2014)

Cytokines and Abnormal Glucose and Lipid Metabolism
por: Shi, Jie, et al.
Publicado: (2019)

Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb
por: Chao, Debra T., et al.
Publicado: (2012)

Role of Lipids and Lipid Metabolism in Prostate Cancer Progression and the Tumor’s Immune Environment
por: Siltari, Aino, et al.
Publicado: (2022)

Alteration of Lipid Metabolism in Prostate Cancer: Multifaceted Oncologic Implications
por: Zeković, Milica, et al.
Publicado: (2023)

The TWEAK-Fn14 System: Breaking the Silence of Cytokine-Induced Skeletal Muscle Wasting
por: Bhatnagar, S, et al.
Publicado: (2012)

Tweaking Microtubules to Treat Scleroderma
por: van Laar, Jacob M, et al.
Publicado: (2005)

Disuse TWEAKs muscle loss
por: Short, Ben
Publicado: (2010)

The “tweaking principle” for task switching
por: Ardid, Salva, et al.
Publicado: (2014)

Lipid metabolism and cancer
por: Bian, Xueli, et al.
Publicado: (2020)

Lipid Metabolism and Cancer
por: Cheng, Hui, et al.
Publicado: (2022)

TWEAKing the Hippocampus: The Effects of TWEAK on the Genomic Fabric of the Hippocampus in a Neuropsychiatric Lupus Mouse Model
por: Iacobas, Dumitru A., et al.
Publicado: (2021)

Lipid Metabolism and Endocrine Resistance in Prostate Cancer, and New Opportunities for Therapy
por: Stoykova, Gergana E., et al.
Publicado: (2019)

Serum sTWEAK and FGF-23 Levels in Hemodialysis and Renal Transplant Patients
por: Eskandari Naji, H., et al.
Publicado: (2017)

High levels of serum soluble TWEAK are associated with neuroinflammation during multiple sclerosis
por: Maarouf, Adil, et al.
Publicado: (2019)

The assessment of the serum levels of TWEAK and prostaglandin F2α in COVID – 19
por: YALÇIN KEHRİBAR, Demet, et al.
Publicado: (2020)

Dynamic of Serum TWEAK Levels in Critically Ill COVID-19 Male Patients
por: Mikacic, Marijana, et al.
Publicado: (2022)

Serum lipid profiles and aggressive prostate cancer
por: Li, Yanjing, et al.
Publicado: (2015)

Posttranslational Modifications of Pyruvate Kinase M2: Tweaks that Benefit Cancer
por: Prakasam, Gopinath, et al.
Publicado: (2018)

HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels
por: López-Dupla, Miguel, et al.
Publicado: (2015)

Role of Metabolism and Metabolic Pathways in Prostate Cancer
por: Wanjari, Uddesh Ramesh, et al.
Publicado: (2023)

Metabolic intervention on lipid synthesis converging pathways abrogates prostate cancer growth
por: Fritz, V, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4iqe9d5k5utbvu6g9t5cf8ek8n